Cargando…

Cardiovascular dysfunction in patients with liver cirrhosis

Hyperdynamic syndrome is a well-known clinical condition found in patients with cirrhosis and portal hypertension, characterized by increased heart rate and cardiac output, and reduced systemic vascular resistance and arterial blood pressure. The leading cause of hyperdynamic circulation in cirrhoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fede, Giuseppe, Privitera, Graziella, Tomaselli, Tania, Spadaro, Luisa, Purrello, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2015
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290002/ https://www.ncbi.nlm.nih.gov/pubmed/25608575

Ejemplares similares

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Cardiovascular dysfunction following spinal cord injury
por: Partida, Elizabeth, et al.
Publicado: (2016)

Metabolic and cardiovascular complications in the liver transplant recipient
por: Luca, Laura De, et al.
Publicado: (2015)

Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept
por: Vlachopoulos, Charalambos, et al.
Publicado: (2015)

C-reactive protein and bacterial infection in cirrhosis
por: Pieri, Giulia, et al.
Publicado: (2014)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

Cardiovascular disease and male sexual dysfunction
por: Miner, Martin, et al.
Publicado: (2015)

Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis
por: Sinakos, Emmanouil, et al.
Publicado: (2022)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Lifestyle modifications and erectile dysfunction: what can be expected?
por: Maiorino, Maria Ida, et al.
Publicado: (2015)

An unusual cause of anemia in cirrhosis: spur cell anemia, a case report with review of literature
por: Privitera, Graziella, et al.
Publicado: (2016)

Occult endocrine dysfunction in patients with cirrhosis of liver
por: Kumar, K. V. S. Hari, et al.
Publicado: (2016)

Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis
por: Wilde, Benjamin, et al.
Publicado: (2019)

The role of general anesthetics and the mechanisms of hippocampal and extra-hippocampal dysfunctions in the genesis of postoperative cognitive dysfunction
por: Cascella, Marco, et al.
Publicado: (2017)

Pathophysiology and treatment of patients with globus sensation ―from the viewpoint of esophageal motility dysfunction―
por: Manabe, Noriaki, et al.
Publicado: (2014)

Endovascular treatment of vasculogenic erectile dysfunction
por: Kim, Edward D, et al.
Publicado: (2015)

Novel mechanisms of endothelial dysfunction in diabetes
por: Yang, Guang, et al.
Publicado: (2010)

Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis
por: Matsui, Osamu, et al.
Publicado: (2011)

Testosterone deficiency and cardiovascular mortality
por: Morgentaler, Abraham
Publicado: (2015)

Sex steroids and cardiovascular disease
por: Yeap, Bu Beng
Publicado: (2014)

TAM receptors in cardiovascular disease
por: McShane, Lucy, et al.
Publicado: (2019)

MicroRNA and Cardiovascular Diseases
por: Çakmak, Hüseyin Altuğ, et al.
Publicado: (2020)

Evaluation of young men with organic erectile dysfunction
por: Papagiannopoulos, Dimitri, et al.
Publicado: (2015)

Diastolic myofilament dysfunction in the failing human heart
por: van der Velden, Jolanda
Publicado: (2011)

Erectile dysfunction and central obesity: an Italian perspective
por: Corona, Giovanni, et al.
Publicado: (2014)

Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review
por: Stundiene, Ieva, et al.
Publicado: (2019)

Factors Predicting Cardiac Dysfunction in Patients with Liver Cirrhosis
por: Behera, Manas Kumar, et al.
Publicado: (2021)

Rare Benign Tumors of the Liver: Still Rare?
por: Bertino, Gaetano, et al.
Publicado: (2014)

Mesenchymal stromal cells for cardiovascular disease
por: Copland, Ian B.
Publicado: (2011)

Transcriptional regulation of endothelial dysfunction in atherosclerosis: an epigenetic perspective
por: Xu, Yong
Publicado: (2014)

Sexual counseling and cardiovascular disease: practical approaches
por: Steinke, Elaine E, et al.
Publicado: (2015)

Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
por: Stein, Anna, et al.
Publicado: (2022)

The role of RhoA/Rho kinase pathway in endothelial dysfunction
por: Yao, Lin, et al.
Publicado: (2010)

Implications of immune-inflammatory responses in smooth muscle dysfunction and disease
por: Usui-Kawanishi, Fumitake, et al.
Publicado: (2020)

Immune Dysfunction in Cirrhosis
por: Noor, Mohd Talha, et al.
Publicado: (2017)

Hyponatremia in Patients with Cirrhosis of the Liver
por: Bernardi, Mauro, et al.
Publicado: (2014)

Malnutrition in Patients with Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2021)

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association
por: Zoccali, Carmine, et al.
Publicado: (2023)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015)

An overview of lymphatic vessels and their emerging role in cardiovascular disease
por: Jones, Dennis, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_16i0186isgbcf9uug0mk8fme0s